Chemed Corporation

CHE
Delayed Nyse - 04/06 10:10:00 pm
437.89USD
+5.18%
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2019 2020 (e)
Sales 1 939 2 144
EBITDA 351 408
Operating profit (EBIT) 301 350
Pre-Tax Profit (EBT) 262 338
Net income 220 257
P/E ratio 33,0x 27,7x
EPS ( $ ) 13,3 15,5
Dividend per Share ( $ ) - 1,28
Yield - 0,30%
Reference price ( $ ) 439,260 427,720
Announcement Date 02/18/2020
09:15pm
-
Finances - Leverage
Actuals in  $ Estimates in  $
Fiscal Period December 2019 2020 (e)
Debt - -
Finance 0,00 0,00
Operating income (EBITDA) 351 408
Leverage
(Debt/EBITDA)
- -
Capital Expenditure - 47,3
Free Cash Flow (FCF) - 263
Book Value Per Share (BVPS) (  ) - -
Cash Flow per Share ( $ ) - 20,6
Announcement Date -
Balance Sheet Analysis
Financial Ratios
Size 2020e 2021e
Capitalization 6 867 M $ -
Valuation 2020e 2021e
P/E ratio (Price / EPS) 27,7x 25,4x
Capitalization / Revenue 3,20x 3,01x
Yield (DPS / Price) 0,30% 0,30%
Price to book (Price / BVPS) - -
Profitability 2020e 2021e
Operating Margin (EBIT / Sales) 16,3% 16,6%
Operating Leverage (Delta EBIT / Delta Sales) 1,51x 1,28x
Net Margin (Net Profit / Revenue) 12,0% 12,2%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) 34,5% -
Rate of Dividend 8,28% 7,61%
Balance Sheet Analysis 2020e 2021e
CAPEX / Sales   2,21% 2,20%
Cash Flow / Sales 15,4% 15,6%
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) - -
Price Earning Ratio
BNA & Dividende